SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2902The one tidbit not in the 8-K: There is a one time (as in "now or never&quotuck-12/23/2011
2901Thanks for reporting on the CC, will be sitting tight on this one too. I am stimopgcw-12/23/2011
2900As expected, CC was uneventful. Although we will get news of milestones, the mituck-12/23/2011
2899I am with you Ian, just sitting tight on a core position for the long haul. didmopgcw-12/23/2011
2898I'm down at a core position. Unless it seriously exceeds its 52 week High (Ian@SI-12/22/2011
2897Yeah, better now. But I'll be looking to unload trading shares and wait fortuck-12/22/2011
2896Hey Tuck, Make that about 6%+. :) After all we're now one trading day beIan@SI-12/22/2011
2895FoB deal with Baxter. Both upfront and royalties less than I expected. Color tuck-12/22/2011
2894CAMBRIDGE, Mass., Dec. 5, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc.nigel bates-12/5/2011
2893>>You think SNY gives a rat’s ass what NVS and MNTA told the Judge? You arIRWIN JAMES FRANKEL411/29/2011
2892<i>>when the court cites representations of MNTA/Sandoz to the effect tDewDiligence_on_SI211/28/2011
2891Of course I read it. Did you read the order? I did. I also appreciate the dutIRWIN JAMES FRANKEL211/28/2011
2890SNY couldn’t care less what the Judge in the MNTA v. Amphastar case thinks aboutDewDiligence_on_SI-11/28/2011
2889" I doubt that SNY’s AG has actually been withdrawn from the market." Rocky9211/28/2011
2888Did you read <i>all</i> of #msg-27791167? I doubt that SNY’s AG has DewDiligence_on_SI-11/28/2011
2887$30-40M per year is a lot of money to MNTA even if not to NVS. Did the contractIRWIN JAMES FRANKEL211/28/2011
2886You’re splitting semantic hairs on the purported distinction between a major ameDewDiligence_on_SI-11/28/2011
2885>>There is no provision in the NVS-MNTA Lovenox agreement to enable that tuck-11/28/2011
2884<i>>All we need now is Sandoz agreeing to return [to] the non-AG profitDewDiligence_on_SI-11/28/2011
2883Amphastar's request for the stay of the preliminary injunction is denied, antuck-11/28/2011
2882<i>>Are you basing your assessment of Natco's glatiramer acetate onDewDiligence_on_SI-11/28/2011
2881Are you basing your assessment of Natco's glatiramer acetate on Teva's stuck-11/28/2011
2880It appears Momenta will use the RBL degranulation test as one method of proving tuck-11/26/2011
2879Eliquis is still a Lovenox competitor, but not in this specific indication. DewDiligence_on_SI111/13/2011
2878looks like one less competitor for MNTA ... New Data Presented On Phase 3 TrialIan@SI111/13/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News